Adipose-derived stromal cells inhibit allergic airway inflammation in mice

Stem Cells and Development

Volumn 19, Issue 11, 2010, Pages 1811-1818

  Park, Hye Kyung ^a   Cho, Kyu Sup ^a   Park, Hee Young ^a   Shin, Dong Hoon ^a   Kim, Yoon Keun ^b   Jung, Jin Sup ^a   Park, Soon Kew ^a   Roh, Hwan Jung ^a  

^a Pusan National University School of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE DERIVED STROMAL CELL; AIRWAY; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; EOSINOPHIL; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LUNG LAVAGE; MOUSE; MUCUS SECRETION; NONHUMAN; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SPLEEN; STROMA CELL; T LYMPHOCYTE; TH2 CELL;

ADIPOSE TISSUE; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CELL MOVEMENT; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; FEMALE; INJECTIONS, INTRAVENOUS; LUNG; MICE; MICE, INBRED BALB C; SPLEEN; STROMAL CELLS; TH2 CELLS;

MUS;

EID: 77956261268     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0513     Document Type: Article

References (29)

1. Cohn L, JA Elias and GL Chupp. (2004). Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 22: 789-815.
2. Busse WW and RF Lemanske Jr. (2001). Asthma. N Engl J Med 344: 350-362.
3. Green RH, CE Brightling, ID Pavord and AJ Wardlaw. (2003). Management of asthma in adults: current therapy and future directions. Postgrad Med J 79: 259-267.
4. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
5. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating; the International Society for Cellular Therapy. (2005). Clarifi cation of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395.
6. Uccelli A, V Pistoia and L Moretta. (2007). Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28: 219-226.
7. Uccelli A, L Moretta and V Pistoia. (2006). Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36: 2566-2573. (Pubitemid 44608440)
8. Tse WT, JD Pendleton, WM Beyer, MC Egalka and EC Guinan. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75: 389-397.
9. Ramasamy R, H Fazekasova, EW Lam, I Soeiro, G Lombardi and F Dazzi. (2007). Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83: 71-76.
10. Di Nicola M, C Carlo-Stella, M Magni, M Milanesi, PD Longoni, P Matteucci, S Grisanti and AM Gianni. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecifi c mitogenic stimuli. Blood 99: 3838-3843.
11. Zappia E, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, D Giunti, A Ceravolo, F Cazzanti, F Frassoni, G Mancardi and A Uccelli. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761.
12. Deng W, Q Han, L Liao, S You, H Deng and RC Zhao. (2005). Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24: 458-463.
13. Dicker A, K Le Blanc, G Aström, V van Harmelen, C Götherström, L Blomqvist, P Arner and M Rydén. (2005). Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res 308: 283-290.
14. Puissant B, C Barreau, P Bourin, C Clavel, J Corre, C Bousquet, C Taureau, B Cousin, M Abbal, P Laharrague, L Penicaud, L Casteilla and A Blancher. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129: 118-129.
15. Yanez R, ML Lamana, J Garcia-Castro, I Colmenero, M Ramirez and JA Bueren. (2006). Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 24: 2582-2591.
16. Bartholomew A, C Sturgeon, M Siatskas, K Ferrer, K McIntosh, S Patil, W Hardy, S Devine, D Ucker, R Deans, A Moseley and R Hoffman. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48.
17. Zhou H, Z Jin, J Liu, S Yu, Q Cui and D Yi. (2008). Mesenchymal stem cells might be used to induce tolerance in heart transplantation. Med Hypotheses 70: 785-787.
18. Lee CG, H Link, P Baluk, RJ Homer, S Chapoval, V Bhandari, MJ Kang, L Cohn, YK Kim, DM McDonald and JA Elias. (2004). Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and infl ammation in the lung. Nat Med 10: 1095-1103.
19. Corne J, G Chupp, CG Lee, RJ Homer, Z Zhu, Q Chen, B Ma, Y Du, F Roux, J McArdle, AB Waxman and JA Elias. (2000). IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest 106: 783-791.
20. Tournoy KG, JC Kips, C Schou and RA Pauwels. (2000). Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin Exp Allergy 30: 79-85.
21. Cho KS, HK Park, HY Park, JS Jung, SG Jeon, YK Kim and HJ Roh. (2009). IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 27: 259-265.
22. Lee RH, B Kim, I Choi, H Kim, HS Choi, K Suh, YC Bae and JS Jung. (2004). Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14: 311-324.
23. Devine SM, C Cobbs, M Jennings, A Bartholomew and R Hoffman. (2003). Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101: 2999-3001.
24. Ortiz LA, F Gambelli, C McBride, D Gaupp, M Baddoo, N Kaminski and DG Phinney. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fi brotic effects. Proc Natl Acad Sci USA 100: 8407-8411.
25. Lange C, F Tögel, H Ittrich, F Clayton, C Nolte-Ernsting, AR Zander and C Westenfelder. (2005). Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68: 1613-1617. (Pubitemid 43169906)
26. Weiss DJ, JK Kolls, LA Ortiz, A Panoskaltsis-Mortari and DJ Prockop. (2008). Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 5: 637-667.
27. Sotiropoulou PA, SA Perez, AD Gritzapis, CN Baxevanis and M Papamichail. (2006). Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24: 74-85.
28. Rasmusson I, O Ringdén, B Sundberg and K Le Blanc. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 305: 33-41.
29. Krampera M, L Cosmi, R Angeli, A Pasini, F Liotta, A Andreini, V Santarlasci, B Mazzinghi, G Pizzolo, F Vinante, P Romagnani, E Maggi, S Romagnani and F Annunziato. (2006). Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398.